Context
Pain is a commonly experienced and distressing symptom in women with breast cancer (BCA), and recent evidence suggests that immune activation may be associated with pain and other co-occurring symptoms. However, no studies to date have explored the relationships among perceived pain and biomarkers of inflammation in women with early-stage BCA during the initial course of treatment but before induction of chemotherapy.
Objectives
The purpose of this research study was to examine the relationships among pro- and anti-inflammatory biomarkers and the presence of pain and other symptoms (anxiety, depression, fatigue, and sleep disorder) in women with early-stage BCA during the initial course of treatment.
Methods
This was a secondary analysis of baseline data from two research studies that measured perceived symptoms, including the presence of pain and pain interference, and plasma levels of pro- and anti-inflammatory cytokines and c-reactive protein (CRP) in women with early-stage BCA (N = 32) at one month after surgery but prior to receiving chemotherapy.
Results
Women experiencing pain had significantly higher levels of CRP (p<.01), interleukin (IL)-13 (p<0.2), IL-7 (p< .02), more pain interference (p<.01), depression (p<.01), and sleep disturbance (p<.01) compared to women reporting no pain. Similar differences were found when examining pain interference groupings. After accounting for differences in type of surgery (breast biopsy, lumpectomy, mastectomy), the presence of pain demonstrated significant positive partial correlations with CRP (rs=0.46, p<.01) and IL-13 (rs =0.36, p=.04).
Conclusion
The presence of pain during the initial course of treatment in women with early-stage BCA was associated with significantly higher levels of CRP and IL-13, suggesting a potential role of immune activation in perceived pain. Further research to examine the precise effects of these biological factors in modulating pain are needed. Perceived pain was also associated with multiple co-occurring symptoms, and this finding has important implications for symptom management. Nursing assessment of pain and pain interference during the early course of BCA treatment may help to identify women who will benefit the most from multimodal symptom management interventions.